SCHEMBL7211320

SCHEMBL7211320

[CH2]CC(N)S(=O)(=O)c1ccc(OC)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.50
MMP13 P45452 11/20 0.49
MMP1 P03956 7/20 0.49
ALDH1A1 P00352 1/20 0.44
PTGS2 P35354 1/20 0.44
F2 P00734 1/20 0.44
PRSS1 P07477 1/20 0.44
PRSS2 P07478 1/20 0.44
PRSS3 P35030 1/20 0.44
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
MMP9 P14780 2/20 0.43
MMP8 P22894 2/20 0.43
MMP2 P08253 1/20 0.43
GAA P10253 1/20 0.43
CA9 Q16790 1/20 0.43
SLC1A3 P43003 1/20 0.42
SLC1A2 P43004 1/20 0.42
SLC1A1 P43005 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7509502 0.81 MMP13 (0.51) PKMMMP13MMP1ALDH1A1PTGS2
SCHEMBL7080813 0.81 PKM (0.48) PKMMMP13MMP1ALDH1A1PTGS2
SCHEMBL27463678 0.80 CA1 (0.47) MMP13MMP1ALDH1A1F2PRSS1
SCHEMBL7207026 0.75 MMP13 (0.68) PKMMMP13MMP1MMP9MMP8
SCHEMBL4195254 0.74 PKM (0.61) PKMMMP13MMP1ALDH1A1PTGS2
SCHEMBL6424727 0.72 PKM (0.50) PKMMMP13MMP1ALDH1A1PTGS2
SCHEMBL8394894 0.72 MMP13 (0.65) MMP13MMP1MMP9MMP8MMP2
SCHEMBL9109608 0.72 PKM (0.59) PKMMMP13MMP1ALDH1A1CA1
SCHEMBL751678 0.72 PKM (0.59) PKMMMP13MMP1ALDH1A1PTGS2
SCHEMBL9732631 0.72 PKM (0.59) PKMMMP13MMP1ALDH1A1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030166687-A1 ALPHA-HYDROXY,-AMINO AND -FLUORO DERIVATIVES OF BETA-SULPHONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS PHARMACIA & UPJOHN COMPANY 2003-09-04 US disclosed
EP-1037868-B1 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS UPJOHN CO (US) 2003-02-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166687-A1 ALPHA-HYDROXY,-AMINO AND -FLUORO DERIVATIVES OF BETA-SULPHONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS MMP1, MMP8, HRH3 PKM 4801/4885MMP13 5/4885MMP1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.